INSIGHTS ON CELL & GENE MANUFACTURING AND LOGISTICS
Biopharma Resilience: Bionova Scientific Talks Capacity, Speed, And Agility Needs
Bionova Scientific shares how a CDMO can offer biopharma companies the flexible capacity they need to meet the growing needs for medicines today and in the future.
How To Choose The Best Filtration Device For Your Application
Learn how to choose the best filtration device for your specific application and understand pore size, membrane material, well volumes and tip types.
Stable Cell Lines For Lentivirus And Gammaretrovirus Production
Explore the advantages and disadvantages of transient transfection and the reasons many viral vector (VV) developers are moving towards using stable producer cell lines for lentiviral vector (LV) development.
Talent And Supply: Building A Foundation For The Future Of Biopharma
Read how to create future-ready facilities supported by advanced scientific knowledge and a secure supply chain that can handle the unprecedented demands and constraints of a post-COVID world.
Top 3 Trends In Cell And Gene Therapy
Discover three trends will help to address current and future issues, accelerate transformations in cell and gene therapy manufacturing, and propel the industry forward.
A Risk-Based Approach To Quality Processes In Life Sciences
Learn how to embed risk-based thinking into quality efforts with an integrated risk management software.
Systems To Facilitate Speed To Market And Manufacture Of New Therapies
Hear how the bioprocessing industry has evolved over the last few years and learn more about our investment in designing modular systems to help speed up the development of life-saving therapies.
Scale-Up Strategies For Cell And Gene Therapy
You need to build the right infrastructure and capabilities into the clinical process to support your product’s commercialization.
Solentim VIPS™ PRO
Watch to learn how VIPS PRO optimizes your workflow productivity and provides complete confidence in single cell seeding and clonality assurance
Build Vs. Outsource For Drug Development & Manufacturing
The decision whether to develop and manufacture a drug in-house or to outsource comprises numerous elements, including costs, timelines, production capacity, and available resources.